• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Onset of action of captopril, enalapril, enalaprilic acid and lisinopril in normal man.

作者信息

Semple P F, Cumming A M, Meredith P A, Morton J J

机构信息

MRC Blood Pressure Unit, Western Infirmary, Glasgow.

出版信息

Cardiovasc Drugs Ther. 1987;1(1):45-50. doi: 10.1007/BF02125832.

DOI:10.1007/BF02125832
PMID:2856460
Abstract

The effects of orally administered captopril, enalapril and lisinopril on plasma concentrations of angiotensin converting enzyme (ACE), angiotensin II (ANGII) and renin (PRC) were studied over a period of 6 hours in 6 normal subjects. A further 4 subjects received intravenous enalapril and enalaprilic acid (enalaprilat). Captopril (25 mg) by mouth caused a fall in pANGII that reached a nadir 30 to 40 minutes after administration but an effect was hardly apparent after 6 hours. Enalapril (10 mg) by mouth had less marked effects on pACE and pANGII with a decline in levels first apparent 1 hour after administration and the lowest levels reached between 3 and 6 hours. Lisinopril (10 mg) produced a progressive fall in pACE and pANGII from 1 hour to reach the lowest values 6 hours after treatment. Intravenous enalaprilat (5 mg) produced an immediate sustained fall in both pACE and pANGII but intravenous enalapril (7 mg) had a biphasic inhibitory effect.

摘要

相似文献

1
Onset of action of captopril, enalapril, enalaprilic acid and lisinopril in normal man.
Cardiovasc Drugs Ther. 1987;1(1):45-50. doi: 10.1007/BF02125832.
2
Regional haemodynamic effects of captopril, enalaprilat and lisinopril in conscious water-replete and water-deprived Brattleboro rats.卡托普利、依那普利拉和赖诺普利对清醒状态下水分充足和缺水的布拉特洛维大鼠的局部血流动力学影响。
Clin Sci (Lond). 1990 Oct;79(4):393-401. doi: 10.1042/cs0790393.
3
Angiotensin converting enzyme inhibitors. Disparities in the mechanism of their antihypertensive effect.血管紧张素转换酶抑制剂。其降压作用机制的差异。
Am J Hypertens. 1988 Jul;1(3 Pt 3):214S-216S. doi: 10.1093/ajh/1.3.214s.
4
Hypotensive effects of angiotensin II analogues and angiotensin converting enzyme inhibitors in water-deprived Brattleboro rats.
J Cardiovasc Pharmacol. 1990 Apr;15(4):562-8. doi: 10.1097/00005344-199004000-00006.
5
[Angiotensin converting enzyme inhibitory activity of MK-0521 in vivo and antihypertensive effect of its single oral administration on blood pressure and effect on the renin-angiotensin system in 2-kidney Goldblatt hypertensive dogs].
Nihon Yakurigaku Zasshi. 1989 Apr;93(4):225-34. doi: 10.1254/fpj.93.225.
6
Lisinopril and nifedipine: no acute interaction in normotensives.赖诺普利与硝苯地平:在血压正常者中无急性相互作用。
Br J Clin Pharmacol. 1988 Mar;25(3):307-13. doi: 10.1111/j.1365-2125.1988.tb03308.x.
7
Clinical pharmacokinetics of the angiotensin converting enzyme inhibitors. A review.血管紧张素转换酶抑制剂的临床药代动力学。综述。
Clin Pharmacokinet. 1985 Sep-Oct;10(5):377-91. doi: 10.2165/00003088-198510050-00001.
8
ACE inhibition and pressor responsiveness to norepinephrine in hypertensive patients.
J Clin Pharmacol. 1990 May;30(5):422-4. doi: 10.1002/j.1552-4604.1990.tb03480.x.
9
Effects on plasma angiotensin-converting enzyme activity and circulating renin of lisinopril and enalapril alone and in combination with propranolol in healthy volunteers.赖诺普利和依那普利单独及与普萘洛尔联合应用对健康志愿者血浆血管紧张素转换酶活性和循环肾素的影响。
Pharmacol Toxicol. 1999 Mar;84(3):110-4. doi: 10.1111/j.1600-0773.1999.tb00884.x.
10
Sheep testicular and epididymal angiotensin converting enzyme: inhibitions by captopril, lisinopril and enalapril.绵羊睾丸和附睾中的血管紧张素转换酶:卡托普利、赖诺普利和依那普利对其的抑制作用。
Biochem Mol Biol Int. 1997 Dec;43(5):1063-70. doi: 10.1080/15216549700204881.

引用本文的文献

1
Lisinopril. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and congestive heart failure.赖诺普利。对其药效学和药代动力学特性以及在高血压和充血性心力衰竭中的治疗用途的初步综述。
Drugs. 1988 Jun;35(6):646-69. doi: 10.2165/00003495-198835060-00003.
2
Tissue and plasma angiotensin converting enzyme and the response to ACE inhibitor drugs.组织和血浆血管紧张素转换酶以及对血管紧张素转换酶抑制剂药物的反应。
Br J Clin Pharmacol. 1991 Jan;31(1):1-13. doi: 10.1111/j.1365-2125.1991.tb03851.x.
3
Comparison of captopril with enalapril in the treatment of heart failure: influence on hemodynamics and measures of renal function.

本文引用的文献

1
Maintenance of blood pressure by the renin-angiotensin system in normal man.
Nature. 1981 May 28;291(5813):329-31. doi: 10.1038/291329a0.
2
A microassay for active and total renin concentration in human plasma based on antibody trapping.基于抗体捕获法的人血浆中活性肾素和总肾素浓度的微量测定法。
Clin Chim Acta. 1980 Feb 14;101(1):5-15. doi: 10.1016/0009-8981(80)90050-9.
3
Pharmacokinetic properties of captopril after acute and chronic administration to hypertensive subjects.卡托普利对高血压患者急性和慢性给药后的药代动力学特性。
卡托普利与依那普利治疗心力衰竭的比较:对血流动力学和肾功能指标的影响。
Cardiovasc Drugs Ther. 1992 Apr;6(2):173-80. doi: 10.1007/BF00054567.
Am J Cardiol. 1982 Apr 21;49(6):1547-9. doi: 10.1016/0002-9149(82)90385-x.
4
Factors related to first dose hypotensive effect of captopril: prediction and treatment.卡托普利首剂降压效应的相关因素:预测与治疗
Br Med J (Clin Res Ed). 1983 Mar 12;286(6368):832-4. doi: 10.1136/bmj.286.6368.832.
5
Angiotensin II levels, hemodynamics, and sympathoadrenal function after low-dose captopril in heart failure.心力衰竭患者服用小剂量卡托普利后的血管紧张素II水平、血流动力学及交感肾上腺功能
Am J Med. 1984 Nov;77(5):880-6. doi: 10.1016/0002-9343(84)90530-8.
6
Enalapril maleate and a lysine analogue (MK-521) in normal volunteers; relationship between plasma drug levels and the renin angiotensin system.正常志愿者中马来酸依那普利与赖氨酸类似物(MK-521);血浆药物水平与肾素-血管紧张素系统之间的关系
Br J Clin Pharmacol. 1982 Sep;14(3):363-8. doi: 10.1111/j.1365-2125.1982.tb01992.x.
7
Pharmacodynamics of converting enzyme inhibition: the cardiovascular, endocrine and autonomic effects of MK421 (enalapril) and MK521.转换酶抑制的药效学:MK421(依那普利)和MK521的心血管、内分泌及自主神经效应
Br J Clin Pharmacol. 1982 Sep;14(3):347-55. doi: 10.1111/j.1365-2125.1982.tb01990.x.
8
A new class of angiotensin-converting enzyme inhibitors.一类新型的血管紧张素转换酶抑制剂。
Nature. 1980 Nov 20;288(5788):280-3. doi: 10.1038/288280a0.
9
The measurement of angiotensin-converting enzyme in subjects receiving captopril.接受卡托普利治疗的受试者体内血管紧张素转换酶的测定。
N Engl J Med. 1980 Aug 14;303(7):397. doi: 10.1056/NEJM198008143030717.
10
Immediate and sustained hemodynamic and clinical improvement in chronic heart failure by an oral angiotensin-converting enzyme inhibitor.口服血管紧张素转换酶抑制剂可使慢性心力衰竭患者即刻并持续出现血流动力学及临床改善。
Circulation. 1980 May;61(5):931-7. doi: 10.1161/01.cir.61.5.931.